Form 8-K - Current report:
SEC Accession No. 0001193125-24-100763
Filing Date
2024-04-18
Accepted
2024-04-18 16:05:54
Documents
13
Period of Report
2024-04-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d805884d8k.htm   iXBRL 8-K 23440
  Complete submission text file 0001193125-24-100763.txt   148583

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cycn-20240418.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycn-20240418_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycn-20240418_pre.xml EX-101.PRE 11712
16 EXTRACTED XBRL INSTANCE DOCUMENT d805884d8k_htm.xml XML 3758
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 24854339
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)